Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...
For more than a century, Mendelian genetics has shaped how we think about inheritance: one gene, one trait. It is a model that still echoes through textbooks—and one that is increasingly reaching its ...
When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that. Genomics is a key part of the health system’s ...
A "genomic-first" approach to screening for rare genetic disorders—identifying specific genetic variants and then studying associated traits and symptoms—can identify these conditions earlier and more ...
As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care ...
Charles Darwin's theory of evolution generated scientific debate and discussion not only in Darwin's own time, but for decades afterward. In the latter part of the nineteenth century and the until the ...
A new study has provided new insights into the the genetic overlap among some psychiatric disorders, and can help explain why it’s not uncommon for several of these disorders to arise in the same ...
Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results